以反复上消化道出血为首发表现的套细胞淋巴瘤一例 - 开云网页登录

主管：开云网页登录
主办：开云网页登录医学院附属瑞金医院
ISSN 1671-2870 CN 31-1876/R

诊断学理论与实践››2020,Vol. 19››Issue (02): 191-194.doi:10.16150/j.1671-2870.2020.02.018

• 病例报告 •上一篇下一篇

以反复上消化道出血为首发表现的套细胞淋巴瘤一例

丁燕飞, 陈平(), 罗方秀, 吴云林

开云网页登录医学院附属瑞金医院北院消化内科,上海 201801

收稿日期:2019-06-10出版日期:2020-04-25发布日期:2020-04-25
通讯作者:陈平 E-mail:chenping714@aliyun.com

Received:2019-06-10Online:2020-04-25Published:2020-04-25

摘要/Abstract

中图分类号:

R735.3

丁燕飞, 陈平, 罗方秀, 吴云林. 以反复上消化道出血为首发表现的套细胞淋巴瘤一例[J]. 诊断学理论与实践, 2020, 19(02): 191-194.

图/表8

图1

图2

图3

图4

图5

图6

图7

图8

参考文献17

[1]	Fakhri B, Kahl B. Current and emerging treatment options for mantle cell lymphoma[J]. Ther Adv Hematol, 2017, 8(8):223-234. doi:10.1177/2040620717719616pmid:28811872
[2]	Vose JM. Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management[J]. Am J Hematol, 2017, 92(8):806-813. doi:10.1002/ajh.24797 URL
[3]	陈灏珠, 林果为, 王吉耀, 等. 实用内科学[M]. 14版. 北京: 人民卫生出版社, 2013:2438-2439.
[4]	Matutes E, Parry-Jones N, Brito-Babapulle V, et al. The leukemic presentation of mantle-cell lymphoma: disease features and prognostic factors in 58 patients[J]. Leuk Lymphoma, 2004, 45(10):2007-2015. doi:10.1080/10428190410001723331 URL
[5]	平凌燕, 郑文, 王小沛, 等. 98例套细胞淋巴瘤临床特点及预后分析[J]. 中国肿瘤临床, 2014, 41(19):1234-1238.
[6]	Tiemann M, Schrader C, Klapper W, et al. Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network[J]. Br J Haematol, 2005, 131(1):29-38. doi:10.1111/j.1365-2141.2005.05716.x URL
[7]	Dasappa L, Suresh Babu MC, Sirsath NT, et al. Primary gastrointestinal mantle cell lymphoma: a retrospective study[J]. J Gastrointest Cancer, 2014, 45(4):481-486. doi:10.1007/s12029-014-9655-2 URL
[8]	Khuroo MS, Khwaja SF, Rather A, et al. Clinicopathological profile of gastrointestinal lymphomas in Kashmir[J]. Indian J Med Paediatr Oncol, 2016, 37(4):251-255. doi:10.4103/0971-5851.195736 URL
[9]	Howell JM, Auer-Grzesiak I, Zhang J, et al. Increasing incidence rates, distribution and histological characteristics of primary gastrointestinal non-Hodgkin lymphoma in a North American population[J]. Can J Gastroenterol, 2012, 26(7):452-456. doi:10.1155/2012/480160 URL
[10]	Radić-Krišto D, Planinc-Peraica A, Ostojić S, et al. Primary gastrointestinal non-Hodgkin lymphoma in adults: clinicopathologic and survival characteristics[J]. Coll Antropol, 2010, 34(2):413-417. pmid:20698111
[11]	Shannon EM, MacQueen IT, Miller JM, et al. Management of Primary Gastrointestinal Non-Hodgkin Lymphomas: a Population-Based Survival Analysis[J]. J Gastrointest Surg, 2016, 20(6):1141-1149. doi:10.1007/s11605-016-3129-8 URL
[12]	Baheti AD, Tirumani SH, Sewatkar R, et al. MDCT of extranodal mantle cell lymphoma: a single institute experience[J]. Abdom Imaging, 2015, 40(6):1693-1699. doi:10.1007/s00261-015-0389-9 URL
[13]	Hu C, Yi C, Dai X. Clinical study of 31 patients with primary gastric mucosa-associated lymphoid tissue lymphoma[J]. J Gastroenterol Hepatol, 2006, 21(4):722-726. doi:10.1111/j.1440-1746.2006.04249.x URL
[14]	Martin P, Ghione P, Dreyling M. Mantle cell lymphoma - Current standards of care and future directions[J]. Cancer Treat Rev, 2017, 58:51-60. doi:S0305-7372(17)30097-Xpmid:28651117
[15]	Spurgeon SE, Till BG, Martin P, et al. Recommendations for Clinical Trial Development in Mantle Cell Lymphoma[J]. J Natl Cancer Inst, 2016, 109(1):263.
[16]	Fakhri B, Kahl B. Current and emerging treatment options for mantle cell lymphoma[J]. Ther Adv Hematol, 2017, 8(8):223-234. doi:10.1177/2040620717719616pmid:28811872
[17]	Rule S, Dreyling M, Goy A, et al. Outcomes in 370 patients with mantle cell lymphoma treated with ibrutinib: a pooled analysis from three open-label studies[J]. Br J Haematol, 2017, 179(3):430-438. doi:10.1111/bjh.14870 URL

相关文章15

编辑推荐

Metrics

本文评价